Cancer drug leads to ‘drastic decrease’ in HIV infection in lung cancer patient

The first evidence that a cancer drug may be able to eradicate HIV-infected cells in humans has now been revealed by researchers. They report that while treating an HIV-infected lung cancer patient with the cancer drug nivolumab, they observed a ‘drastic and persistent decrease’ in the reservoirs of cells in the body where the human immunodeficiency virus (HIV) is able to hide away from attack by antiretroviral therapy.